These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8357775

  • 1. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF, Timour Q, Larbre JP, Loufoua-Moundanga J, Kioueh I, Lopez M, Faucon G.
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [Abstract] [Full Text] [Related]

  • 2. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
    Timour Q, Aupetit JF, Loufoua-Moundanga J, Gerentes-Chassagne I, Kioueh I, Faucon G.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
    [Abstract] [Full Text] [Related]

  • 3. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
    Faucon G, Aupetit JF, Gerentes-Chassagne I, Loufoua-Moundanga J, Larbre JP, Timour Q.
    Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
    [Abstract] [Full Text] [Related]

  • 4. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q.
    Pharmacotherapy; 1997 Feb; 17(4):737-45. PubMed ID: 9250551
    [Abstract] [Full Text] [Related]

  • 5. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF, Loufoua-Moundanga J, Faucon G, Timour Q.
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [Abstract] [Full Text] [Related]

  • 6. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q.
    Arch Int Pharmacodyn Ther; 1996 Feb; 331(3):246-62. PubMed ID: 9124997
    [Abstract] [Full Text] [Related]

  • 7. Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide.
    Lang J, Timour Q, Aupetit JF, Lancon JP, Lakhal M, Faucon G.
    Arch Int Pharmacodyn Ther; 1988 Feb; 293():97-108. PubMed ID: 3138954
    [Abstract] [Full Text] [Related]

  • 8. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q, Aupetit JF, Loufoua-Moundanga J, Kioueh I, Omar S, Chevrel G, Faucon G.
    Fundam Clin Pharmacol; 1992 Feb; 6(4-5):159-67. PubMed ID: 1427561
    [Abstract] [Full Text] [Related]

  • 9. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP, van der Linde HJ, Van Deuren B, Somers Y, Lubomirski M, Teisman A, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2015 Feb; 72():72-84. PubMed ID: 25450838
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
    Lacroix D, Delfaut P, Adamantidis M, Cardinal R, Klug D, Kacet S, Dupuis B.
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578
    [Abstract] [Full Text] [Related]

  • 11. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF, Freysz M, Faucon G, Loufoua-Moundanga J, Coquelin H, Timour Q.
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [Abstract] [Full Text] [Related]

  • 12. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF, Bui-Xuan B, Kioueh I, Loufoua J, Frassati D, Timour Q.
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [Abstract] [Full Text] [Related]

  • 13. [Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
    Timour Q, Aupetit JF, Loufoua-Moundanga JL, Barral-Cadière L, Freysz M, Faucon G.
    Therapie; 1994 Mar; 49(4):349-53. PubMed ID: 7878603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF, Fabritz CL, Franz MR.
    Circulation; 1998 Jun 30; 97(25):2567-74. PubMed ID: 9657478
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute ischemia, early extrabeats and propafenone on complex activation patterns in intact and ischemic canine hearts.
    Bauer A, Becker R, Voss F, Senges JC, Kraft P, Schreiner KD, Kuebler W, Schoels W.
    Life Sci; 2003 May 02; 72(24):2751-67. PubMed ID: 12679192
    [Abstract] [Full Text] [Related]

  • 17. Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine.
    Freysz M, Timour Q, Bertrix L, Loufoua-Moundanga J, Omar S, Faucon G.
    Acta Anaesthesiol Scand; 1993 May 02; 37(4):350-6. PubMed ID: 8322562
    [Abstract] [Full Text] [Related]

  • 18. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M, Lazzarotti M, Facchini M, Schwartz PJ.
    Am Heart J; 1994 Nov 02; 128(5):973-82. PubMed ID: 7524295
    [Abstract] [Full Text] [Related]

  • 19. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U, Stark G, Kasper K, Schwarzl I, Decrinis M, Pilger E, Tritthart HA.
    Pacing Clin Electrophysiol; 1997 Jan 02; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [Abstract] [Full Text] [Related]

  • 20. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF.
    Presse Med; 1985 Mar 23; 14(12):685-9. PubMed ID: 3157964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.